Balyasny Asset Management LLC Dice Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $23.6 Million - $42.7 Million	913,940 New	913,940 $42.5 Million
Q4 2022 Feb 14, 2023	SELL	$19.77 - $42.23 $1.21 Million - $2.58 Million	-61,200 Reduced 13.31%	398,477 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $2.77 Million - $4.19 Million	184,856 Added 67.26%	459,677 $9.32 Million
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $3.62 Million - $6.07 Million	274,821 New	274,821 $4.27 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.